Posted on

cbd 3 1

Cbd 3 1

The potency in the 5:1 is a total (TTL) of 200mg, however you can see that there is approximately five times the amount of CBD in relation to the amount of THC. Many guests will start with .3 ml (1/2 of a standard serving). Because all producers are required to list the potency, tinctures and edibles make it easy to control your serving.

1:1 Ratio – Having equal parts CBD and THC seems to be the most effective in tackling pain management. The goal of utilizing a 1:1 product is to induce a gentle buzz while allowing the consumer to function and focus throughout the day. While CBD affects inflammation throughout the body, THC regulates neurotransmitters and how the brain perceives pain. The 1:1 ratio provides both mental and physical relief from pain. While this ratio is not considered “recreational”, 1:1 products can be easily found at most dispensaries. 2

Let’s Explore a 5:1 Ratio Cannabis Product

Anytime you see a product that features a ratio, the first number will reflect the amount of CBD in a product. The second number featured shows the amount of THC in the same product. For example, a 10:1 Ratio tincture has 10x the amount of CBD as THC. It is important to know that CBD comes first, as you may come across ratios that have more THC than CBD. Each ratio has its own range of effects, so it’s best to talk with a medical consultant to find the ratio that best suits your needs.

1:2 Ratio – This ratio allows you to enjoy the psychoactive effects of THC, with an enhanced body high from the CBD. Often recommended as a sleep aid, this ratio can be more sedative depending on the terpene profile of the product. 4

Common Ratios

5:1 Ratio – This ratio is an excellent place to start for those who are new to cannabis, or experienced consumers who are looking for products that will allow them to function without intoxication. Fairwinds 5:1 Ratio Tincture offers an invigorating blend of terpenes to accentuate the therapeutic benefits of the CBD. 3

Introduction: Preclinical and clinical studies suggest that cannabidiol (CBD) found in Cannabis spp. has broad therapeutic value. CBD products can currently be purchased online, over the counter and at Cannabis-specific dispensaries throughout most of the country, despite the fact that CBD is generally deemed a Schedule I controlled substance by the U.S. Drug Enforcement Administration and renounced as a dietary supplement ingredient by the U.S. Food and Drug Administration. Consumer demand for CBD is high and growing, but few studies have examined the reasons for increasing CBD use. Materials and Methods: A self-selected convenience sample (n = 2409) was recruited via an online survey designed to characterize whom, how, and why individuals are currently using CBD. The anonymous questionnaire was accessed from October 25, 2017 to January 25, 2018. Participants were recruited through social media. Results: Almost 62% of CBD users reported using CBD to treat a medical condition. The top three medical conditions were pain, anxiety, and depression. Almost 36% of respondents reported that CBD treats their medical condition(s) “very well by itself,” while only 4.3% reported “not very well.” One out of every three users reported a nonserious adverse effect. The odds of using CBD to treat a medical condition were 1.44 (95% confidence interval, 1.16-1.79) times greater among nonregular users of Cannabis than among regular users. Conclusion: Consumers are using CBD as a specific therapy for multiple diverse medical conditions-particularly pain, anxiety, depression, and sleep disorders. These data provide a compelling rationale for further research to better understand the therapeutic potential of CBD.

Keywords: CBD; anxiety; cannabidiol; cannabis; marijuana; pain.